Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

Epilepsy Research
M ShariefR M Karim

Abstract

The efficacy and safety of topiramate 400 mg/day as adjunctive therapy to traditional antieleptic drugs for partial onset seizures with or without secondary generalization were assessed in a double-blind, parallel-group, placebo-controlled trial. Forty-seven patients with at least one seizure per week during an 8 week baseline were randomly assigned to topiramate (N = 23) or placebo (N = 24) double-blind treatment for a 3 week titration and an 8 week stabilization period. Median percent reduction from baseline in monthly seizure frequency during the double-blind phase was not significantly greater in the topiramate group than in the placebo group (41% vs. 1%; P = 0.065). Nevertheless, other efficacy variables evidenced statistically significant differences in favor of topiramate: a greater number of treatment responders (> or = 50% reduction in seizures; 35% vs. 8%; P = 0.033); better investigator (P = 0.002) and patient (P = 0.021) global assessments; and greater reductions in secondarily generalized seizures compared to placebo (P = 0.002). The most commonly reported topiramate treatment-emergent adverse events were somnolence, fatigue, abnormal vision, weight decrease, and anxiety. Most adverse events were mild or moderate i...Continue Reading

Citations

Nov 3, 2004·Pediatric Neurology·Abla M Albsoul-YounesSaafan A Al-Safi
Mar 5, 2004·Survey of Ophthalmology·Michael S Vaphiades, John Mason
Oct 7, 2003·Epilepsy & Behavior : E&B·Andres M KannerUNKNOWN PADS Investigators
Jun 23, 2000·Biological Psychiatry·S L McElroyR M Post
Jul 10, 2003·Survey of Ophthalmology·Rod Foroozan, Lawrence M Buono
Jan 28, 1998·Clinical Therapeutics·W E Rosenfeld
May 1, 1997·Clinical Therapeutics·M K Bazil, C W Bazil
Sep 30, 1999·Controlled Clinical Trials·E Lesaffre, G Pledger
Nov 27, 1998·Pediatric Neurology·S L Kugler, R C Sachdeo
Jun 17, 1999·Pediatric Neurology·W E RosenfeldR A Reife
Sep 12, 2003·Seizure : the Journal of the British Epilepsy Association·Rajiv Mohanraj, Martin J Brodie
Aug 13, 1998·Seizure : the Journal of the British Epilepsy Association·P Crawford
Aug 16, 2003·Journal of Paediatrics and Child Health·D ReithJ Pelekanos
Oct 23, 2002·Headache·Randal L Von SeggernJames U Adelman
Jul 15, 2000·Clinical Neuropharmacology·B F Bourgeois
Jul 20, 2002·International Clinical Psychopharmacology·U WernekeT A B Sanders
May 31, 2006·Psychiatry and Clinical Neurosciences·Jacques ThuileJulien-Daniel Guelfi
Jul 20, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H StefanB Schmidt
Oct 26, 1999·Epilepsia·M D Privitera
Oct 26, 1999·Epilepsia·T A Glauser
Jul 1, 1999·Epilepsia·J A CramerR H Mattson
Aug 29, 2000·Epilepsia·L J StephenM J Brodie
Apr 18, 2000·Epilepsia·S Skradski, H S White
Apr 18, 2000·Epilepsia·T A GlauserK McGee
Mar 24, 1998·Annual Review of Medicine·C W Bazil, T A Pedley
May 12, 2010·Clinical Interventions in Aging·B R Sommer, H H Fenn
Oct 3, 2001·Epilepsia·W O TatumUNKNOWN PADS Investigators. Post-marketing antiepileptic drug survey
Apr 21, 2010·Expert Opinion on Pharmacotherapy·Benjamin Cretin, Edouard Hirsch
May 7, 2014·Expert Opinion on Pharmacotherapy·Sylvain Rheims, Philippe Ryvlin
Nov 19, 2009·Epilepsy & Behavior : E&B·A B GuekhtE I Gusev

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.